Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Codex DNA stock

Learn how to easily invest in Codex DNA stock.

Codex DNA is a medical devices business based in the US. Codex DNA shares (DNAY) are listed on the NASDAQ and all prices are listed in US Dollars. Codex DNA employs 212 staff and has a trailing 12-month revenue of around $21 million.

How to buy Codex DNA stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – DNAY. It's that simple.

Best for beginners

Finder Award


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • Get $10 when you sign up and deposit $100

Promoted for easy user experience


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Codex DNA stock price (NASDAQ: DNAY)

Use our graph to track the performance of DNAY stocks over time.

Codex DNA shares at a glance

Information last updated 2023-01-18.
Latest market close$1.76
52-week range$1.08 - $11.02
50-day moving average $1.44
200-day moving average $2.27
Wall St. target price$6.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.84

Buy Codex DNA stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Codex DNA stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Codex DNA price performance over time

Historical closes compared with the close of $1.76 from 2023-01-25

1 week (2023-01-19) -11.11%
1 month (2022-12-23) 41.94%
3 months (2022-10-26) -1.68%
6 months (2022-07-26) -7.37%
1 year (2022-01-26) -74.34%
2 years (2021-01-22) N/A
3 years (2020-01-22) N/A
5 years (2018-01-22) N/A

Codex DNA financials

Revenue TTM $21 million
Gross profit TTM $4.3 million
Return on assets TTM -29.63%
Return on equity TTM -67.7%
Profit margin -251.05%
Book value $1.81
Market capitalisation $38.4 million

TTM: trailing 12 months

Codex DNA share dividends

We're not expecting Codex DNA to pay a dividend over the next 12 months.

You may also wish to consider:

Codex DNA overview

Codex DNA, Inc. , a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020.

Frequently asked questions

What percentage of Codex DNA is owned by insiders or institutions?
Currently 37.137% of Codex DNA shares are held by insiders and 43.579% by institutions.
How many people work for Codex DNA?
Latest data suggests 212 work at Codex DNA.
When does the fiscal year end for Codex DNA?
Codex DNA's fiscal year ends in December.
Where is Codex DNA based?
Codex DNA's address is: 9535 Waples Street, San Diego, CA, United States, 92121-2993
What is Codex DNA's ISIN number?
Codex DNA's international securities identification number is: US1920031010

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site